Common polymorphisms in the complement system and susceptiblity to bacterial meningitis.

[1]  A. Zwinderman,et al.  Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. , 2011, The Journal of clinical investigation.

[2]  L. Katz,et al.  Allelic Variants of Complement Genes Associated with Dense Deposit Disease , 2011, Journal of the American Society of Nephrology : JASN.

[3]  D. Fearon,et al.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk , 2011, Proceedings of the National Academy of Sciences.

[4]  J. Reitsma,et al.  Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis , 2010, Neurology.

[5]  John D Lambris,et al.  Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.

[6]  Diederik van de Beek,et al.  Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis , 2010, Clinical Microbiology Reviews.

[7]  M. Lipsitch,et al.  The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model. , 2010, Vaccine.

[8]  C. Khor,et al.  Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease , 2010, Nature Genetics.

[9]  B. Fridley,et al.  Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[10]  A. Hofman,et al.  Complement component C3 and risk of age-related macular degeneration. , 2008, Ophthalmology.

[11]  A. Zwinderman,et al.  Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. , 2009, The Lancet. Infectious diseases.

[12]  H. Pfister,et al.  Myeloid Src kinases regulate phagocytosis and oxidative burst in pneumococcal meningitis by activating NADPH oxidase , 2008, Journal of leukocyte biology.

[13]  A. van der Ende,et al.  Clinical Features, Outcome, and Meningococcal Genotype in 258 Adults With Meningococcal Meningitis: A Prospective Cohort Study , 2008, Medicine.

[14]  J. Haines,et al.  C3 R102G polymorphism increases risk of age-related macular degeneration. , 2008, Human molecular genetics.

[15]  Jeffrey N. Weiser,et al.  The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease , 2008, Nature Reviews Microbiology.

[16]  D. Briles,et al.  PspA and PspC Minimize Immune Adherence and Transfer of Pneumococci from Erythrocytes to Macrophages through Their Effects on Complement Activation , 2007, Infection and Immunity.

[17]  Johanna M Seddon,et al.  Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.

[18]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[19]  B. Schmand,et al.  Cognitive outcome in adults after bacterial meningitis , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[20]  H. Pfister,et al.  Complement C1q and C3 Are Critical for the Innate Immune Response to Streptococcus pneumoniae in the Central Nervous System1 , 2007, The Journal of Immunology.

[21]  Wouter A Dreschler,et al.  Dexamethasone and long‐term outcome in adults with bacterial meningitis , 2006, Annals of neurology.

[22]  M. van Deuren,et al.  Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. , 2006, Blood.

[23]  T. Poll,et al.  Pneumococcal meningitis in adults: new approaches to management and prevention , 2006, The Lancet Neurology.

[24]  T. Mitchell,et al.  Innate immunity and the pneumococcus. , 2006, Microbiology.

[25]  J. Reitsma,et al.  Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series , 2006, The Lancet Neurology.

[26]  Allan R Tunkel,et al.  Community-acquired bacterial meningitis in adults. , 2006, The New England journal of medicine.

[27]  M. Hibberd,et al.  Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients , 2006, Scandinavian journal of infectious diseases.

[28]  G. Jönsson,et al.  Hereditary C2 Deficiency in Sweden: Frequent Occurrence of Invasive Infection, Atherosclerosis, and Rheumatic Disease , 2005, Medicine.

[29]  Martijn Weisfelt,et al.  Clinical features and prognostic factors in adults with bacterial meningitis. , 2004, The New England journal of medicine.

[30]  S. Meri,et al.  Complement resistance mechanisms of streptococci. , 2003, Molecular immunology.

[31]  G. G. Hardy,et al.  Genetic Alteration of Capsule Type but Not PspA Type Affects Accessibility of Surface-Bound Complement and Surface Antigens of Streptococcus pneumoniae , 2003, Infection and Immunity.

[32]  B. Schmand,et al.  Cognitive impairment in adults with good recovery after bacterial meningitis. , 2002, The Journal of infectious diseases.

[33]  R. Westendorp,et al.  Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. , 2001, The Journal of infectious diseases.

[34]  I. Kluijt,et al.  A family with complement factor D deficiency. , 2001, The Journal of clinical investigation.

[35]  L. Truedsson,et al.  Properdin deficiency: molecular basis and disease association. , 1999, Molecular immunology.

[36]  A. Tomasz,et al.  The role of complement in inflammation during experimental pneumococcal meningitis. , 1986, Microbial pathogenesis.